The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of the body, shipped to a specialized facility, genetically reprogrammed, ...
Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a glo | Embecta ...
Embecta (Nasdaq:EMBC) announced today that it entered into a definitive agreement to acquire Owen Mumford Holdings Limited.
The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.
With the duo 12000 US, the Austria-based plastics processing equipment maker opens up new dimensions in cost-efficient part ...
Gerresheimer has launched Gx InMonit, a smart add-on device for autoinjectors, along with Gx AdheraLink, an AI-driven messaging solution, to improve patient adherence to home-based injection therapies ...
March 17, 2026 - PRESSADVANTAGE - Motor vehicle accidents continue to be a leading cause of serious injury across ...
MGS says Auto-injector Reimagined drug-delivery device, which harnesses its design and moldmaking capabilities, can help ...
E3 LITHIUM LTD. (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), "E3", "E3 Lithium" or the "Company," a leader in Canadian lithium ...
What you need to handle the chassis-bending stages of the Dakar Classic Rally is the world’s most dependable SUV made even tougher. We get up close and personal with a specially prepared 70 Series ...
Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...
The new Red Bull F1 car is pulling out all the stunts and stops this week in San Francisco. Video from Red Bull showed its F1 car doing some tricks earlier this week in the Pacific Heights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results